社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
乐山大佛笑哈哈
IP属地：广东
+关注
帖子 · 222
帖子 · 222
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
乐山大佛笑哈哈
乐山大佛笑哈哈
·
03-13 12:08
$佑驾创新(02431)$
10元以下？
看
24
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
乐山大佛笑哈哈
乐山大佛笑哈哈
·
03-13 12:07
$派格生物医药-B(02565)$
市场分析认为，公司已形成“PB-119（已获批周制剂）与CR059（在研月级制剂）”的产品组合，实现了从“周”到“月”给药周期的技术覆盖，构筑了长期竞争壁垒
看
97
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
乐山大佛笑哈哈
乐山大佛笑哈哈
·
03-11
$大唐发电(00991)$
明天继续涨
看
172
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
乐山大佛笑哈哈
乐山大佛笑哈哈
·
03-11
$果下科技(02655)$
果下核心产品与解决方案精准契合两会提出的新型电力系统建设、智能电网升级、绿电应用扩大等核心需求，成为国家储能战略落地的重要产业载体
看
203
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
乐山大佛笑哈哈
乐山大佛笑哈哈
·
03-11
$中广核新能源(01811)$
明天还能继续大涨
看
39
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
乐山大佛笑哈哈
乐山大佛笑哈哈
·
03-11
$智谱(02513)$
智谱 的Pony-Alpha-2模型在工具调用能力、响应速度及稳定性等方面展现出较强的综合性能，能够更出色地应对 OpenClaw 中的典型乃至高级应用场景
看
315
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
乐山大佛笑哈哈
乐山大佛笑哈哈
·
03-09
$特斯拉(TSLA)$
盘前交易不理想啊
看
155
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
乐山大佛笑哈哈
乐山大佛笑哈哈
·
03-09
$中慧生物-B(02627)$
公司自主研发的国内首款全人群三价流感病毒亚单位疫苗（慧尔康欣3）成功中标山西省非免疫规划疫苗增补采购项目，标志着该重磅新品从获批迅速走向市场销售，开始贡献实际收入
看
66
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
乐山大佛笑哈哈
乐山大佛笑哈哈
·
03-05
$超微电脑(SMCI)$
继续搞上去
看
252
回复
评论
点赞
1
编组 21备份 2
分享
举报
乐山大佛笑哈哈
乐山大佛笑哈哈
·
03-05
$派格生物医药-B(02565)$
对于长线投资者，指数纳入和产品管线构成长期利好；但短期股价受市场情绪、资金面和事件博弈影响，波动性较高
看
123
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4203843771083212","uuid":"4203843771083212","gmtCreate":1740740593407,"gmtModify":1740740666896,"name":"乐山大佛笑哈哈","pinyin":"lsdfxhhleshandafoxiaohaha","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":5,"tweetSize":222,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":542103138947432,"gmtCreate":1773374892959,"gmtModify":1773374894735,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4203843771083212","authorIdStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02431\">$佑驾创新(02431)$ </a> 10元以下？","listText":"<a href=\"https://laohu8.com/S/02431\">$佑驾创新(02431)$ </a> 10元以下？","text":"$佑驾创新(02431)$ 10元以下？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/542103138947432","isVote":1,"tweetType":1,"viewCount":24,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":542103009751400,"gmtCreate":1773374861417,"gmtModify":1773374863545,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4203843771083212","authorIdStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 市场分析认为，公司已形成“PB-119（已获批周制剂）与CR059（在研月级制剂）”的产品组合，实现了从“周”到“月”给药周期的技术覆盖，构筑了长期竞争壁垒","listText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 市场分析认为，公司已形成“PB-119（已获批周制剂）与CR059（在研月级制剂）”的产品组合，实现了从“周”到“月”给药周期的技术覆盖，构筑了长期竞争壁垒","text":"$派格生物医药-B(02565)$ 市场分析认为，公司已形成“PB-119（已获批周制剂）与CR059（在研月级制剂）”的产品组合，实现了从“周”到“月”给药周期的技术覆盖，构筑了长期竞争壁垒","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/542103009751400","isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":541460063740792,"gmtCreate":1773217965674,"gmtModify":1773217967343,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4203843771083212","authorIdStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/00991\">$大唐发电(00991)$ </a> 明天继续涨","listText":"<a href=\"https://laohu8.com/S/00991\">$大唐发电(00991)$ </a> 明天继续涨","text":"$大唐发电(00991)$ 明天继续涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/541460063740792","isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":541460233532352,"gmtCreate":1773217938292,"gmtModify":1773219979226,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4203843771083212","authorIdStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02655\">$果下科技(02655)$ </a> 果下核心产品与解决方案精准契合两会提出的新型电力系统建设、智能电网升级、绿电应用扩大等核心需求，成为国家储能战略落地的重要产业载体","listText":"<a href=\"https://laohu8.com/S/02655\">$果下科技(02655)$ </a> 果下核心产品与解决方案精准契合两会提出的新型电力系统建设、智能电网升级、绿电应用扩大等核心需求，成为国家储能战略落地的重要产业载体","text":"$果下科技(02655)$ 果下核心产品与解决方案精准契合两会提出的新型电力系统建设、智能电网升级、绿电应用扩大等核心需求，成为国家储能战略落地的重要产业载体","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/541460233532352","isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":541456668397928,"gmtCreate":1773217063235,"gmtModify":1773217065159,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4203843771083212","authorIdStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/01811\">$中广核新能源(01811)$ </a> 明天还能继续大涨","listText":"<a href=\"https://laohu8.com/S/01811\">$中广核新能源(01811)$ </a> 明天还能继续大涨","text":"$中广核新能源(01811)$ 明天还能继续大涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/541456668397928","isVote":1,"tweetType":1,"viewCount":39,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":541456523347240,"gmtCreate":1773217034949,"gmtModify":1773217037405,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4203843771083212","authorIdStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02513\">$智谱(02513)$ </a> 智谱 的Pony-Alpha-2模型在工具调用能力、响应速度及稳定性等方面展现出较强的综合性能，能够更出色地应对 OpenClaw 中的典型乃至高级应用场景","listText":"<a href=\"https://laohu8.com/S/02513\">$智谱(02513)$ </a> 智谱 的Pony-Alpha-2模型在工具调用能力、响应速度及稳定性等方面展现出较强的综合性能，能够更出色地应对 OpenClaw 中的典型乃至高级应用场景","text":"$智谱(02513)$ 智谱 的Pony-Alpha-2模型在工具调用能力、响应速度及稳定性等方面展现出较强的综合性能，能够更出色地应对 OpenClaw 中的典型乃至高级应用场景","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/541456523347240","isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":540836697191944,"gmtCreate":1773058341891,"gmtModify":1773058343759,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4203843771083212","authorIdStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$ </a> 盘前交易不理想啊","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$ </a> 盘前交易不理想啊","text":"$特斯拉(TSLA)$ 盘前交易不理想啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/540836697191944","isVote":1,"tweetType":1,"viewCount":155,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":540836879630560,"gmtCreate":1773058308418,"gmtModify":1773058310792,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4203843771083212","authorIdStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 公司自主研发的国内首款全人群三价流感病毒亚单位疫苗（慧尔康欣3）成功中标山西省非免疫规划疫苗增补采购项目，标志着该重磅新品从获批迅速走向市场销售，开始贡献实际收入","listText":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 公司自主研发的国内首款全人群三价流感病毒亚单位疫苗（慧尔康欣3）成功中标山西省非免疫规划疫苗增补采购项目，标志着该重磅新品从获批迅速走向市场销售，开始贡献实际收入","text":"$中慧生物-B(02627)$ 公司自主研发的国内首款全人群三价流感病毒亚单位疫苗（慧尔康欣3）成功中标山西省非免疫规划疫苗增补采购项目，标志着该重磅新品从获批迅速走向市场销售，开始贡献实际收入","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/540836879630560","isVote":1,"tweetType":1,"viewCount":66,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":539371380594216,"gmtCreate":1772700599029,"gmtModify":1772700601175,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4203843771083212","authorIdStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/SMCI\">$超微电脑(SMCI)$ </a> 继续搞上去","listText":"<a href=\"https://laohu8.com/S/SMCI\">$超微电脑(SMCI)$ </a> 继续搞上去","text":"$超微电脑(SMCI)$ 继续搞上去","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/539371380594216","isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":539371165406368,"gmtCreate":1772700575288,"gmtModify":1772700577612,"author":{"id":"4203843771083212","authorId":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4203843771083212","authorIdStr":"4203843771083212"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 对于长线投资者，指数纳入和产品管线构成长期利好；但短期股价受市场情绪、资金面和事件博弈影响，波动性较高","listText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 对于长线投资者，指数纳入和产品管线构成长期利好；但短期股价受市场情绪、资金面和事件博弈影响，波动性较高","text":"$派格生物医药-B(02565)$ 对于长线投资者，指数纳入和产品管线构成长期利好；但短期股价受市场情绪、资金面和事件博弈影响，波动性较高","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/539371165406368","isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}